Literature DB >> 10752981

Gab-family adapter molecules in signal transduction of cytokine and growth factor receptors, and T and B cell antigen receptors.

M Hibi1, T Hirano.   

Abstract

Gab1 and Gab2 (Grb2 associated binder 1 and 2) are scaffolding adapter molecules that display sequence similarity with Drosophila DOS (daughter of sevenless), which is a potential substrate for the protein tyrosine phosphatase, Corkscrew, Both Gab1 and Gab2, like DOS, have a pleckstrin homology domain and potential binding sites for SH2 and SH3 domains. Gab1 and Gab2 are phosphorylated on tyrosine upon the stimulation of various cytokines, growth factors, and antigen receptors, and interact with signaling molecules, such as Grb2, SHP-2, and PI-3 kinase. Overexpression of Gab1 or Gab2 mimics or enhances growth factor or cytokine-mediated biological processes and activates ERK MAP kinase. These data imply that Gab1 and Gab2 act downstream of a broad range of cytokine and growth factor receptors, as well as T and B antigen receptors, and link these receptors to ERK MAP kinase and biological actions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752981     DOI: 10.3109/10428190009089430

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  21 in total

1.  Grb2-associated binding (Gab) proteins in hematopoietic and immune cell biology.

Authors:  Tamisha Y Vaughan; Sheetal Verma; Kevin D Bunting
Journal:  Am J Blood Res       Date:  2011

2.  Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.

Authors:  S H Ong; Y R Hadari; N Gotoh; G R Guy; J Schlessinger; I Lax
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

3.  Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways.

Authors:  Xiao-Xia Fang; Xiao-Lin Jiang; Xin-Hua Han; Yu-Ping Peng; Yi-Hua Qiu
Journal:  Cell Mol Neurobiol       Date:  2012-11-16       Impact factor: 5.046

4.  Gab2 plays distinct roles in bone homeostasis at different time points.

Authors:  Shousaku Itoh; Fumio Yoshitake; Hiroko Narita; Katsuhiko Ishihara; Shigeyuki Ebisu
Journal:  J Bone Miner Metab       Date:  2007-02-26       Impact factor: 2.626

5.  Gads/Grb2-mediated association with LAT is critical for the inhibitory function of Gab2 in T cells.

Authors:  Sho Yamasaki; Keigo Nishida; Machie Sakuma; Donna Berry; C Jane McGlade; Toshio Hirano; Takashi Saito
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.

Authors:  Tsuyoshi Akagi; Kazutaka Murata; Tomoyuki Shishido; Hidesaburo Hanafusa
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 7.  Protein kinases and associated pathways in pluripotent state and lineage differentiation.

Authors:  Melina Shoni; Kathy O Lui; Demetrios G Vavvas; Michael G Muto; Ross S Berkowitz; Nikolaos Vlahos; Shu-Wing Ng
Journal:  Curr Stem Cell Res Ther       Date:  2014       Impact factor: 3.828

8.  Combined detection of Gab1 and Gab2 expression predicts clinical outcome of patients with glioma.

Authors:  Hui Liu; Gang Li; Weitao Zeng; Pengxing Zhang; Feiyan Fan; Yanyang Tu; Yongsheng Zhang
Journal:  Med Oncol       Date:  2014-07-08       Impact factor: 3.064

9.  The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway.

Authors:  Betty Lamothe; Masashi Yamada; Ute Schaeper; Walter Birchmeier; Irit Lax; Joseph Schlessinger
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

10.  Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase.

Authors:  Yupeng He; Haruhisa Nakao; Seng-Lai Tan; Stephen J Polyak; Petra Neddermann; Sangeetha Vijaysri; Bertram L Jacobs; Michael G Katze
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.